Nuveen Asset Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $410K | Sell |
32,059
-10,765
| -25% | -$138K | ﹤0.01% | 3045 |
|
|
2024
Q3 | $1.18M | Buy |
42,824
+661
| +2% | +$18.2K | ﹤0.01% | 2678 |
|
|
2024
Q2 | $1.22M | Sell |
42,163
-440
| -1% | -$12.8K | ﹤0.01% | 2630 |
|
|
2024
Q1 | $1.9M | Buy |
42,603
+6,128
| +17% | +$273K | ﹤0.01% | 2429 |
|
|
2023
Q4 | $1.42M | Sell |
36,475
-88
| -0.2% | -$3.41K | ﹤0.01% | 2574 |
|
|
2023
Q3 | $1.07M | Buy |
36,563
+7,005
| +24% | +$206K | ﹤0.01% | 2546 |
|
|
2023
Q2 | $1.88M | Buy |
29,558
+7,178
| +32% | +$457K | ﹤0.01% | 2369 |
|
|
2023
Q1 | $1.06M | Sell |
22,380
-2,471
| -10% | -$117K | ﹤0.01% | 2587 |
|
|
2022
Q4 | $1.73M | Sell |
24,851
-4,334
| -15% | -$301K | ﹤0.01% | 2454 |
|
|
2022
Q3 | $4.28M | Sell |
29,185
-707
| -2% | -$104K | ﹤0.01% | 1993 |
|
|
2022
Q2 | $3.9M | Buy |
29,892
+2,202
| +8% | +$287K | ﹤0.01% | 2111 |
|
|
2022
Q1 | $2.83M | Buy |
27,690
+24,046
| +660% | +$2.46M | ﹤0.01% | 2353 |
|
|
2021
Q4 | $662K | Buy |
3,644
+1,354
| +59% | +$246K | ﹤0.01% | 2996 |
|
|
2021
Q3 | $678K | Buy |
+2,290
| New | +$678K | ﹤0.01% | 3111 |
|